Inventor · disambiguated record
Andreas Wilmen
Also filed as: WILMEN ANDREAS
14 granted patents·10 pending applications·45 citations·filing 2010–2025
89Inventor score
Top patents by PatentIndex Score
24 records- 0185US10221247B2Antibodies capable of binding to the coagulation factor XIa and uses thereofBayer Pharma AG·Filed 2017·Granted Mar 5, 2019·5 cites·12 claims
- 0285US9783614B2Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor Xia and uses thereofBayer Pharma AG·Filed 2013·Granted Oct 10, 2017·7 cites·6 claims
- 0385US9382305B2Relaxin fusion polypeptides and uses thereofWILMEN ANDREAS·Filed 2012·Granted Jul 5, 2016·20 cites·17 claims
- 0480US9777063B2Neutralizing prolactin receptor antibody Mat3 and its therapeutic useBAYER IP GMBH·Filed 2016·Granted Oct 3, 2017·3 cites·4 claims
- 0577US12215168B2Anti-A2AP antibodies and uses thereofBAYER AG·Filed 2023·Granted Feb 4, 2025·0 cites·15 claims
- 0676US9649374B2Neutralizing prolactin receptor antibodies and their therapeutic useOTTO CHRISTIANE·Filed 2010·Granted May 16, 2017·5 cites·5 claims
- 0774US10040866B2Nucleic acids and host cells expressing antibodies capable of binding to the coagulation factor XIa and uses thereofBayer Pharma AG·Filed 2017·Granted Aug 7, 2018·1 cites·12 claims
- 0871US2024034810A1Anti-a2ap antibodies and uses thereofBAYER AG·Filed 2023·Application pending·0 cites
- 0971US2025236654A1C-type natriuretic peptide engrafted antibodiesBAYER AG·Filed 2024·Application pending·0 cites
- 1068US9241989B2Neutralizing prolactin receptor antibodies and their therapeutic useOTTO CHRISTIANE·Filed 2010·Granted Jan 26, 2016·2 cites·16 claims
- 1167US11046783B2Antibodies capable of binding to the coagulation factor XIa and uses thereofBayer Pharma AG·Filed 2019·Granted Jun 29, 2021·0 cites·16 claims
- 1266US9353186B2Neutralizing prolactin receptor antibody Mat3 and its therapeutic useFREIBERG CHRISTOPH·Filed 2012·Granted May 31, 2016·2 cites·14 claims
- 1363US2024010750A1Novel anti-a2ap antibodies and uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 1461US2025361282A1Atrial natriuretic peptide engrafted antibodiesBAYER AG·Filed 2025·Application pending·0 cites
- 1559US12331094B2Atrial natriuretic peptide engrafted antibodiesBAYER AG·Filed 2019·Granted Jun 17, 2025·0 cites·18 claims
- 1656US2021079056A1C-type natriuretic peptide engrafted antibodiesBAYER AG·Filed 2019·Application pending·0 cites
- 1748US2021395390A1Reversal agents for neutralizing the therapeutic activity of anti-fxia antibodiesBAYER AG·Filed 2019·Application pending·0 cites
- 1847US12390508B2Brain natriuretic peptide engrafted antibodiesBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 19, 2025·0 cites·17 claims
- 1943US11077187B2Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereofOKLAHOMA MED RES FOUND·Filed 2016·Granted Aug 3, 2021·0 cites·17 claims
- 2043US10654941B2Antibodies against factor XI and uses thereofBayer Pharma AG·Filed 2017·Granted May 19, 2020·0 cites·20 claims
- 2143US2016009776A1Pdgfrbeta-fc fusion proteins and uses thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2241US2015307625A1MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C (aPC)BAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
- 2339US2015329613A1Fusion polypeptides and uses thereofBayer Pharma AG·Filed 2013·Application pending·0 cites
- 2439US2014148390A1Fusion proteins releasing relaxin and uses thereofHAUPTS ULRICH·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Wilmen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →